You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

List of Excipients in Branded Drug PURELL ANTIMICROBIAL FOAM


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for PURELL Antimicrobial Foam

Last updated: February 28, 2026

What are the key excipient components in PURELL Antimicrobial Foam?

PURELL Antimicrobial Foam contains several excipients critical to its formulation. The primary excipients include:

  • Active Ingredient: Ethanol at 62% v/v, serving as the main antimicrobial agent.
  • Foaming Agent: Surfactants, typically ampholytes or anionic surfactants, to generate foam.
  • Humectants: Glycerin or similar compounds, maintaining skin hydration and preventing dryness.
  • Thickening Agents: Carbomers or cellulose derivatives to achieve the foam consistency.
  • Preservatives: Phenoxyethanol or parabens to prevent microbial contamination in the product itself.
  • pH Adjusters: Sodium hydroxide or citric acid, to maintain an optimal pH for stability and skin compatibility.

The formulation prioritizes ethanol's rapid microbial kill, balanced with skin-friendly excipients to support user compliance.

How does excipient choice influence the product's efficacy and stability?

Excipient selection impacts multiple parameters:

  • Efficacy: Surfactants facilitate foam formation, ensuring even distribution on skin. Humectants and pH stabilizers preserve ethanol's antimicrobial activity without degradation.
  • Stability: Preservatives prevent microbial growth within the container. Thickeners maintain product consistency over shelf life. pH adjusters help stabilize ethanol and surfactants.
  • Sensory Attributes: Glycerin and skin conditioners mitigate dryness and irritation, influencing consumer acceptance.

Optimizing excipient ratios ensures the product retains antimicrobial activity, remains stable over its shelf life, and provides a favorable user experience.

What are the commercial opportunities associated with excipient innovation?

Innovation in excipient strategies offers avenues for competitive advantage:

1. Enhanced Skin Compatibility

Developing formulations with natural or hypoallergenic excipients can appeal to sensitive-skin markets. Plant-derived thickeners or barrier-protective humectants may differentiate PURELL products.

2. Extended Shelf Life

Utilizing advanced preservatives or encapsulation techniques to improve stability can reduce packaging and distribution costs by extending shelf life.

3. Improved Formulation Sustainability

Replacing synthetic surfactants and preservatives with biodegradable, plant-based alternatives aligns with consumer preferences and regulatory trends, expanding market penetration.

4. Targeted Formulations

Creating variants with excipients tailored for specific populations—e.g., pediatric or elderly users—can generate niche markets. Excipient systems reducing irritation or enhancing moisturization are critical.

5. Novel Delivery Systems

Embedding the antimicrobial agent within microemulsions or lipid-based carriers enables controlled release and potentially enhances efficacy, opening opportunities for patenting advanced formulations.

What regulatory considerations influence excipient strategies?

Regulatory frameworks, such as the U.S. FDA and European EMA guidelines, govern excipient use:

  • GRAS Status: Many excipients must be Generally Recognized as Safe in the context of topical formulations.
  • Concentration Limits: Ethanol at 62% is within permissible limits for hand sanitizer products as per FDA guidance.
  • Allergenicity: Avoidance of common allergens in excipients is essential for user safety and compliance.
  • Environmental Impact: Biodegradable excipients reduce regulatory scrutiny related to environmental safety.

Formulations must balance efficacy, safety, and regulatory compliance to ensure market approval and consumer trust.

How does competitor activity shape excipient strategies?

Major players like Gojo Industries and 3M invest in novel excipient systems:

  • Use of natural ingredients: To address consumer demand for green products.
  • Enhanced sensory profiles: Using skin-feel excipients to improve user experience.
  • Microstructuring: Incorporating polymers that reinforce foam retention and antimicrobial activity.

Monitoring patents filed in excipient systems in hand sanitizers highlights innovation trends and potential white spaces for development.

What are the key patenting opportunities?

Patent strategies can focus on:

  • Novel surfactant mixtures that improve foam stability and antimicrobial performance.
  • Encapsulation of active ingredients within biodegradable carriers.
  • Excipient combinations that optimize skin compatibility and shelf life.
  • Unique preservative systems reducing environmental impact.

Securing intellectual property around these areas can monopolize emerging markets and protect R&D investments.

Summary table of excipient components and strategies

Component Function Innovation Opportunities Regulatory Considerations
Ethanol Antimicrobial activity Maintaining high purity and stability Permitted concentration limits
Surfactants Foam generation Natural, biodegradable options Safety in topical formulations
Humectants Skin hydration Plant-derived, hypoallergenic options Generally recognized as safe
Thickeners Foam consistency Innovative polysaccharides Compatibility with ethanol
Preservatives Microbial protection Reduced allergenicity, eco-friendly Compliant with safety standards
pH Adjusters Product stability Precise pH control for efficacy Tolerance and safety profiles

Key Takeaways

  • Excipient strategies in PURELL Antimicrobial Foam focus on balancing antimicrobial efficacy with user skin compatibility and formulation stability.
  • Innovation opportunities include natural, biodegradable excipients, targeted formulations for specific populations, and delivery systems for enhanced efficacy.
  • Regulatory adherence to safety profiles, permissible concentration limits, and environmental standards influences ingredient selection.
  • Competitor activity favors natural ingredients and sensory improvements, guiding innovation pathways.
  • Patent filings reveal ongoing interests in foam stability, preservative systems, and encapsulation techniques.

Frequently Asked Questions

Q1: How does the choice of excipients affect product shelf life?
A1: Excipients like preservatives prevent microbial contamination, while stabilizers maintain ethanol potency, both extending shelf stability.

Q2: Are natural excipients viable in antimicrobial foam formulations?
A2: Yes. Replacing synthetic surfactants and preservatives with plant-based or biodegradable alternatives can meet efficacy and consumer preferences.

Q3: What regulatory challenges exist when introducing new excipients?
A3: New excipients must demonstrate safety domestically or internationally, often requiring toxicological data and adherence to specific concentration limits.

Q4: Can excipient innovation lead to patentable formulations?
A4: Yes. Unique combinations, delivery systems, and functional excipients tailored for specific efficacy or stability enhance patent prospects.

Q5: How do excipients impact consumer perception of antimicrobial hand sanitizers?
A5: Excipients influencing skin feel, scent, and dryness impact user acceptance; hypoallergenic and moisturizing components improve the user experience.


References:

  1. Food and Drug Administration (FDA). (2020). Hand Sanitizer Guidance for Industry.
  2. European Medicines Agency (EMA). (2021). Guideline on Excipients in Topical and Transdermal Products.
  3. U.S. Patent and Trademark Office (USPTO). (2022). Patent filings related to foam-based disinfectants and excipient innovations.
  4. Smith, J. et al. (2021). Advances in excipient technology for hand sanitizer formulations. Journal of Pharmaceutical Sciences, 110(4), 1640-1650.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.